Displaying 1 - 5 of 5
| Active Ingredient | CIPROFLOXACIN |
| Therapeutic Class | QUINOLONES |
| Indications |
Ciprofloxacin is effective in a variety of infections due to gram- positive and gram-negative pathogens, including multi-resistant strains. It is also indicated for us in individuals exposed to inha More ... |
| Caution | Gastrointestinal disturbances; CNS side effects, including seizures. Increases in transaminases and in some cases severe and fatal hepatitis have developed. Hematuria and anaphylactic reactions have More ... |
| Dose Range | Adult: 250-750mg twice daily, depending on the severity of the infection. Inhalational post-exposure anthrax: 500mg every 12 hours. Pediatric: inhalational p ost-exposure anthrax: 10mg/kg every 12 hours. Maximum 400mg daily. See BDS supply protocols |
| Drug Interactions | |
| Pregnancy | Avoid in pregnancy—shown to cause arthropathy in animal studies; safer alternati More ... |
| Breast Feeding | Amount too small to be harmful but manufacturer advises avoid. |
| Active Ingredient | LEVOFLOXACIN |
| Therapeutic Class | QUINOLONES |
| Indications | Community -acquired pneumonia, urinary -tract infections, chronic prostatitis, complicated skin and soft tissue infections. |
| Caution | Constipation; flatulence (in adults); hyperhidrosis (in adults). The drug should be discontinued if psychiatric, neurological, or hypersensitivity reactions (including severe rash) occur. |
| Dose Range | Adult: 250 to 500 mg once or twice daily for 7 to 14 days depending on the severity and nature of the infection. Chronic prostatitis: 500mg once daily for 28 days. |
| Drug Interactions | |
| Pregnancy | Avoid in pregnancy—shown to cause arthropathy in animal studies; safer alternati More ... |
| Breast Feeding | Manufacturer advises use only if potential benefit outweighs risk. |
| Active Ingredient | MOXIFLOXACIN |
| Therapeutic Class | QUINOLONES |
| Indications | Bacterial conjunctivitis. |
| Caution | Taste disturbances, ocular discomfort, irritation and dryness, hyperaemia, photophobia, visual disturbances and nasal discomfort. |
| Dose Range |
Adult and child over 1 month: 3 times daily, continue treatment for 2-3 days after infection improves. |
| Drug Interactions | |
| Pregnancy | Avoid in pregnancy—shown to cause arthropathy in animal studies; safer alternati More ... |
| Breast Feeding |
| Active Ingredient | NORFLOXACIN |
| Therapeutic Class | QUINOLONES |
| Indications | Urinary tract infections, uncomp licated gonorrhea, and p rostatitis. |
| Caution | Headache, depression, dizziness, nausea, vomiting, vaginal irritation and finger joint swelling. Take on an emp ty stomach with a large glass of water, drink several glasses of water during treatm More ... |
| Dose Range |
Uncomplicated UTI: 400mg twice daily for 3-10 days; Complicated UTI: 400mg twice daily for 10-21 days. Uncomplicated gonorrhea: 800mg as a single dose. Acute or Chronic Prostatitis: 400mg twice daily for 28 days. See BDS supply protocols pg. 3. |
| Drug Interactions | |
| Pregnancy | Avoid in pregnancy—shown to cause arthropathy in animal studies; safer alternati More ... |
| Breast Feeding |
| Active Ingredient | OFLOXACIN |
| Therapeutic Class | QUINOLONES |
| Indications | Uncomplicated gonorrhea, nongonococcal urethritis, acute pelvic inflammatory disease, acute uncomplicated cystitis, complicated urinary tract infections,chronic bacterial prostatitis. |
| Caution | Nausea, insomnia, headache, dizziness, diarrhea, vomiting, rash, and pruritus. The safety and efficacy of ofloxacin in pediatric patients and adolescents (under age 18 years), and pregnant and lactati More ... |
| Dose Range | 200mg-400mg twice daily. A single oral dose of 400mg is indicated for uncomplicated gonorrhea. See BDS supply protocols pg. 3. |
| Drug Interactions | |
| Pregnancy | Avoid in pregnancy—shown to cause arthropathy in animal studies; safer alternati More ... |
| Breast Feeding | Amount probably too small to be harmful but manufacturer advises avoid |